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In addition to their central role in allergy, mast cells are involved in a wide variety of cellular
interactions during homeostasis and disease. In this review, we discuss the ability of mast
cells to extend their mechanisms for intercellular communication beyond the release of
soluble mediators. These include formation of mast cell synapses on antigen presenting
surfaces, as well as cell–cell contacts with dendritic cells andT cells. Release of membrane
bound exosomes also provide for the transfer of antigen, mast cell proteins, and RNA to
other leukocytes.With the recognition of the extended role mast cells have during immune
modulation, further investigation of the processes in which mast cells are involved is nec-
essary. This reopens mast cell research to exciting possibilities, demonstrating it to be an
immunological frontier.
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INTRODUCTION
Mast cell IgE-driven responses are critical to immunity against
invading parasites. However, in developed countries where par-
asitic infections are minimal, these cells have become central
to allergic responses. Thus allergy-related issues have been the
primary focus of mast cell research for several decades. The cen-
tral player in most studies has been the high-afﬁnity IgE recep-
tor, FcεRI. Following antigen-mediated crosslinking, the FcεRI
signaling pathway stimulates secretion of mast cell soluble fac-
tors (i.e., histamine, leukotrienes, prostaglandins, and cytokines)
responsible for allergic symptoms.
In the last decade, the immunological role of mast cells has been
steadily expanding. Mast cells regulate other immune cells via the
wide variety of cytokines and chemokines secretedupon activation
(Galli and Wershil, 1995; Bachelet and Levi-Schaffer, 2007). Addi-
tionally,mast cells express receptors thatmediate innate immunity,
such as toll-like receptors (TLRs; Supajatura et al., 2001; Mat-
sushima et al., 2004), leading to the hypothesis that mast cells
can play a signiﬁcant role in immune responses to infection and
other environmental challenges. This hypothesis is strongly sup-
ported by evidence that mast cells inﬂuence the behavior of T
cells (Hershko and Rivera, 2010; Valitutti and Espinosa, 2010) B
cells (Merluzzi et al., 2010), dendritic cells (Shelburne et al., 2009;
Dawicki et al., 2010), macrophages (Ketavarapu et al., 2008), neu-
rons (Buhner and Schemann, 2012), and even tumor cells (Ribatti
and Crivellato, 2011). Importantly, mast cells and other immune
cells interact in complex ways that include both soluble mediators
and direct contact. Here, we focus speciﬁcally on the mechanisms
by which mast cells communicate with other hematopoietic cells
via cell–cell contacts (“synapses”) and delivery of mast cell cargo
through binding and uptake of membrane-derived vesicles (“exo-
somes”). The rapidly accelerating pace of the ﬁeld suggests that
we have just begun to appreciate the importance of mast cells in
the immune system, and that this is indeed an exciting frontier in
inﬂammatory research.
MAST CELL SYNAPSES
One way in which immune cells communicate to modulate sys-
temic responses is through direct contact, such as that seen with
formation of the immunological synapse (Thery et al., 2009;
Dustin et al., 2010). Mast cells participate in mast-T cell synapse
formation as antigen presenting cells, which is possible through
mast cell display of peptide-loaded MHCII and co-stimulatory
molecules (Bhattacharyya et al., 1998; Valitutti and Espinosa,
2010). MHCII surface expression by primary mouse mast cells
(bone marrow and peritoneal derived mast cells; BMMCs, PCMC)
and human mast cell lines requires stimulation with IFNγ or
IL-4 treatment during growth (Grabbe et al., 1997; Gauden-
zio et al., 2009; Valitutti and Espinosa, 2010). In this context,
mast cells and T cells can form a “traditional” immunologic
synapse that mediates antigen-speciﬁc T cell activation. It is rea-
sonable to speculate that this may be an important feature in
establishing and maintaining the atopic state, since one impor-
tant outcome of IgE-mediated crosslinking is the endocytosis
of antigen (Pfeiffer et al., 1985). Once delivered to secretory
lysosomal compartments, allergens are subjected to proteoly-
sis, and peptides are generated with potential for loading onto
MHCII.
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We considered the possibility that mast cells could also be on
the “receiving” end of a synapse, if presented with antigen on
the surface of another cell. Like the T cell and B cell receptors
(TCR, BCR), FcεRI is a multisubunit immuno-receptor that uti-
lizes ITAM motifs to initiate a tyrosine kinase signaling cascade
(Tamir andCambier,1998).As initial test of this possibility,wepre-
sented IgE-primedmast cells with a planar, lipid bilayer containing
mobile, cognate, monovalent ligand. This represents a modiﬁca-
tion of the technique ﬁrst developed by Dustin et al. (1996) to
characterize the T cell synapse.
We were able to conﬁrm that a number of mast cells (includ-
ing MC/9, RBL-2H3 cell lines, and primary BMMCs) readily form
FcεRI-centric synapses upon recognition of antigen within bilay-
ers (Carroll-Portillo et al., 2010; Figure 1, from Lidke and Wilson
Labs). These synapses are remarkably similar to those seen with T
cells and B cells (Carrasco et al., 2004; Dustin, 2008), suggesting
that themechanisms for synapse formation are shared amongmost
leukocyte lineages.Asmast cells primedwithDNP-speciﬁc IgE set-
tle onto a ﬂuid bilayer containing monovalent DNP-lipid, FcεRI–
IgE complexes at the contact points bind the cognate ligand within
the bilayer surface. As synapse development progresses, additional
FcεRI–IgE accumulate at the centralized portion of the contact-
ing membrane (Figure 1A). Like T and B cells (Lin et al., 2008;
Sheﬂer et al., 2010), the actin cytoskeleton undergoes rearrange-
ment to concentrate at the cell periphery, and becomes largely
excluded from the central regions containing engaged receptors
(Figure 1B). Cholesterol also concentrates within the contacting
membrane where engaged FcεRI–IgE reside (Figure 1C); in con-
junction with the loss of underlying actin cytoskeleton, this allows
for unconﬁned mobility of engaged receptors. Furthermore, only
bound FcεRI–IgE segregates into the ﬂuid region of the contacting
membrane as demonstrated by failure of IgE speciﬁc for a second
antigen to partition there (Figure 1D).
While soluble monovalent antigen is insufﬁcient to stimulate
degranulation from mast cells (Pfeiffer et al., 1985), presenta-
tion of monovalent ligand within the bilayer results in a low,
but statistically signiﬁcant level of degranulation (Carroll-Portillo
et al., 2010). This result is best explained by the observation that
up to 3× 105 IgE receptors accumulate at the contacting mem-
brane. This high density markedly increases the rate of encounters
between IgE–FcεRI complexes. Since the receptors remain highly
mobile, thesemonovalent interactionsmust be extremely transient
but collectively generate sufﬁcient kinase activation to propagate
measureable stimulatory signals.
Pharmacologic studies further established the contributions of
actin andLyn/Fynkinase activity tomast cell synapse organization.
Treatment of IgE-primed mast cells with the actin-disrupting drug
Latrunculin B prior to addition to the DNP-lipid bilayer resulted
in disruption of synapse architecture (Figure 1E, upper row). In
contrast, mast cells treated with PP2 (a Src family kinase inhibitor
that targets themast cell kinases Lyn andFyn) could form synapses,
but the cytoskeleton reorganization was incomplete (Figure 1E,
lower row). These observations support the conclusion that actin
remodeling at the synapse is downstreamof local kinase activation.
Do mast cell synapses of this type occur in vivo? We expect so,
especially in the context of live parasites and bacteria whose cell
membranes are decorated with antigenic epitopes. Early electron
microscopy evidencedemonstrated tight bindingbetween rat peri-
toneal mast cells and Schistosoma mansoli larvae (Caulﬁeld et al.,
1981) andBMMCsdegranulatewhen incubatedwith liveLeishma-
nia (Bidri et al., 1997). Antibody-mediated direct contact can also
lead to mast cell phagocytosis of the parasite (Saha et al., 2004).
An important outstanding question is whether other mast cell
receptors implicated in direct binding to pathogens, such as the
TLRs and the mannose-binding protein CD48 (Marshall, 2004)
also reorganize into synapse-like structures at the point of contact.
There is also strong evidence that contact of mast cells with
activated T cells can lead to mast cell degranulation and cytokine
production (Bhattacharyya et al., 1998). This is dependent upon
integrin (LFA-1) and ICAM interactions between the adherent
cells (Inamura et al., 1998), and can occur in the context of mast
cell antigenpresentation (Gaudenzio et al., 2009). Thusmast cell-T
cell synapses can lead to bi-directional signaling, creating a posi-
tive feedback situation expected to drive inﬂammatory responses
in tissues (Mekori and Baram, 2002).
THE SPECIAL CASE OF MAST CELL-DENDRITIC CELL
CONTACTS
In addition to T cells and B cells, mast cells also affect the func-
tion and trafﬁcking of dendritic cells. Dendritic cells and mast
cells are both ubiquitous in tissue at the environmental inter-
faces, and both can affect immune responses after detection of
invading pathogens (Gurish and Austen, 2001; Soloff and Barratt-
Boyes, 2010; Wesolowski and Paumet, 2011). Importantly, these
cells are in close proximity allowing for response by dendritic cells
to mast cell soluble mediators and the formation of direct contacts
(Figure 2A, from Cambi and Lidke Labs). Thus, mast cells and
dendritic cells are potential partners in modulation of immune
responses to environmental changes.
Dendritic cells have long been considered the sentinels of the
immune system (Cella et al., 1997; Banchereau and Steinman,
1998). They reside in an immature state within the tissue and
work in this environment to sample antigens through phagocyto-
sis. Upon stimulation with inﬂammatory cytokines or recognition
of a non-self antigen, dendritic cells begin trafﬁcking through
the tissue to the draining lymph node. Several maturation mark-
ers become upregulated (such as CD80, CD40, CD86, MHCII,
and CCR7), and antigen is presented to lymphocyte populations
within the lymph node to stimulate proliferation, thus initiating
the immune response.
Mast cells secrete a remarkable repertoire of soluble media-
tors, including histamine, leukotrienes, prostaglandins, cytokines,
and chemokines. Close proximity of mast cells within the tissue,
as well as the numerous cytokine/chemokine receptors expressed
by dendritic cells, allows for response to these soluble mediators
upon mast cell activation. Supernatant from activated mast cells
has been shown to induce upregulation of dendritic cell matura-
tion markers in mouse and human systems (Caron et al., 2001;
Kitawaki et al., 2006), increase CCL21 chemotaxis to the drain-
ing lymph nodes (Shelburne et al., 2009; Ren et al., 2010), and
stimulate Th2-promoting dendritic cells (Kitawaki et al., 2006).
Speciﬁcally, histamine and TNFα play large roles in these changes.
TNFα works locally to increase the expression of E-cadherin
that, in conjunction with other inﬂammatory cytokines, serves
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FIGURE 1 | Characteristics of the mast cell synapse. (A) Confocal section
demonstrating synapse formed by a MC/9 mast cell primed with α-DNP
IgEA488 after 20min on a 25mol% DNP-lipid bilayer. (B) Structure of the actin
cytoskeleton in a RBL cell primed with α-DNP IgEA488 after 20min on a
25mol% DNP-lipid bilayer. Confocal section of cells ﬁxed with
paraformaldehyde and then labeled with rhodamine phalloidin to visualize
actin. (C)Total internal reﬂection ﬂuorescence microscopy (TIRFm) image of
an RBL cell repleted with FITC-conjugated cholesterol and primed with α-DNP
IgEA555 after 20min on a 25mol% DNP-lipid bilayer. (D) Confocal section of
RBLs co-primed with equal concentrations of α-DNP IgEA488 and α-dansyl
IgEA555 and settled onto 25mol% DNP-lipid bilayers after 20min. (E) Confocal
sections of RBLs primed with α-DNP IgEA555 and pretreated with either
Latrunculin B (upper row) or PP2 (lower row) settled on 25mol% DNP-lipid
bilayers for 20min. Cells were paraformaldehyde ﬁxed and stained with A488
phalloidin. All images have been brightness and contrast enhanced. Scale
bars are 5μm.
to recruit dendritic cells to the site of infection (Shelburne et al.,
2009). Peripherally, TNFα stimulates changes within the lymph
node environment causing enlargement (Kunder et al., 2009) and
increased expression of CCL21 with subsequent upregulation of
dendritic cell chemotaxis (Shelburne et al., 2009; Ren et al., 2010).
Histamine also locally stimulates upregulation of dendritic cell
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FIGURE 2 | Interactions between mast cells and dendritic cells.
(A) Immunohistochemistry of normal human intestinal and colon tissue
double stained for mast cell tryptase (brown) and CD209 (DC-SIGN, pink).
Arrows within blown up sections indicate regions where direct contact
between the two cell types is observed. (B) Live cell, confocal imaging of a
mouse bone marrow-derived mast cell primed with α-DNP IgEA488 (green)
directly interacting with a mouse bone marrow-derived dendritic cell after
activation with DNP–BSA. Arrows indicate where mast cell internalized
material has been transferred to the dendritic cell. All images have been
brightness and contrast enhanced.
maturation markers and expression of Th2-associated cytokines,
even in the presence of LPS and IFNγ that on their own would
drive a Th1-promoting dendritic cell response (Caron et al., 2001;
Kitawaki et al., 2006). Histamine increases dendritic cell capacity
to stimulate proliferation of memory T cell populations (Caron
et al., 2001), and results in the peripheral recruitment of speciﬁc
dendritic cell to the draining lymph node (Dawicki et al., 2010).
All of the previous examples represent interactions in response to
inﬂammatory signals. However, mast cells also regulate dendritic
cell behavior in the absence of inﬂammation,as seen in the instance
of allograft tolerance (de Vries et al., 2011). In contrast to den-
dritic cell trafﬁcking in response to inﬂammatory signals,GM-CSF
(most likely produced by the local mast cell population) within the
grafted area represses mast cell degranulation (e.g., inﬂammation)
and increases the longevity of the immature dendritic cell popu-
lation. This, in combination with mast cell-secreted TNFα, results
in increased trafﬁcking of immature dendritic cells to the drain-
ing lymph node and serves to stimulate allograft tolerance in the
absence of T cell proliferation. Mast cells are indispensable for
mediation of dendritic cell tolerance of allografts demonstrating
another example of intercellular communication through soluble
factors.
Although soluble interactions between mast cells and dendritic
cells are well characterized, the effects of direct contact are just
starting to be investigated in the context of both homeostasis
(Dudeck et al., 2011) and disease (Kitawaki et al., 2006; Bacci
et al., 2010; Otsuka et al., 2011). The consequences of direct inter-
action between activated mast cells and dendritic cells are similar
to those seen with soluble mediators. Thus, direct contact can
lead to upregulation of maturation markers, increased expres-
sion of Th2-speciﬁc cytokines, increased dendritic cell chemotaxis
to the lymph node, and enhanced T cell stimulation (Kitawaki
et al., 2006; Otsuka et al., 2011). It is possible that direct con-
tact in these instances stimulates dendritic cells when only a few
mast cells become activated within the tissue. Contact would
allow for delivery of more concentrated doses of soluble medi-
ators, as well as stimulating a small population of dendritic cells
to respond to minimal stimulus to prime the immune system.
This hypothesis is supported by the physiological changes that
occur within FcεRI-activated mast cells upon contact with den-
dritic cells. Internalized receptor complexes (with antigen bound)
become polarized within the mast cell with subsequent transfer
of internalized material to dendritic cells (Figure 2B, from Cambi
and Lidke Labs). Material transferred could become processed
and presented to lymphocyte populations within the lymph node.
Dudeck et al. (2011) demonstrate that activation of mast cells
through FcεRI is not required for dendritic cell stimulation as
interaction between peritoneal-derived mast cells and dendritic
cells also results in slight, but signiﬁcant upregulation of dendritic
cell maturation markers, secretion of certain Th1 and Th17 polar-
izing cytokines, and proliferation of the CD4+ T cell population.
These changes become enhanced with the addition of LPS and
occur in the absence of mast cell degranulation, demonstrating a
non-FcεRI related role for mast cells in immune modulation.
So far, in vitro interactions between mast cells and dendritic
cells have been addressed using both primary cell systems as well
as established cell lines (for the mast cells). However, there is
an added level of complexity to these interactions in vivo due
to the different classes of dendritic cells (e.g., myeloid dendritic
cells, plasmacytoid dendritic cells, langerhans cells, dermal den-
dritic cells, etc; Kaplan, 2010; Romani et al., 2010; Kushwah and
Hu, 2011) and mast cell subtypes (e.g., mucosal and connective
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tissue). With populations of dendritic cells originating from dif-
ferent precursors and both mast cells and dendritic cells from
different tissues exhibiting varied receptor repertoire and activa-
tion patterns, mast cell-dendritic cell partnerships are likely tissue
speciﬁc. For example, dendritic cells residing in the skin display
a completely different phenotype when compared to intestinal or
blood dendritic cells. Not only does this highlight the impressive
plasticity of the dendritic cell population, but it also demonstrates
the likelihood that cellular interactions are in part dictated by the
surrounding environment. The challenge ahead is to understand
the interplay between mast cells and dendritic cell subsets that may
vary among different tissues.
EXOSOMES
The variety of mast cell soluble mediators secreted upon mast
cell activation lead to modulation of immune cells both locally
and at distal sites (Galli and Wershil, 1995). However, these dif-
fusible messengers lack long term stability within the body. Here,
we consider the evidence that mast cell-derived exosomes offer
an additional mechanism for intercellular communication. These
membrane bound vesiclesmight be expected to have greater stabil-
ity in the blood and interstitial spaces, and they uniquely provide
a means of material exchange between cells since their uptake by
other immune cells delivers a “payload” to the recipient cell.
Exosomes originate from part of the endosomal pathway
(Stoorvogel et al., 2002). They are small vesicles (60–100 nm) that
reside in multi-vesicular bodies (MVBs) within cells until stimu-
lated exocytosis releases them into the extracellular milieu. MVBs
are formed when the membranes of vacuolar endosomes bud
inwards and pinch off into the lumen of the vesicle; this process
can result in accumulation of many small vesicles within the same
endosomal compartment. It is their size as well as their biophysi-
cal and biochemical properties that serve to distinguish exosomes
from other types of membrane vesicles secreted by cells (reviewed
in Thery et al., 2009). Vesicles within MVBs are thought to have
three potential fates: fusion with the lysosomal pathway to target
proteins and lipids for degradation, long term residency within
the MVBs to serve as protein storage compartments, or serving as
a source of exosomes that are shed into the extracellular milieu
upon fusion of the MVB with the plasma membrane. Exosomes
are bounded by a classical bilayer structure with a speciﬁc lipid
composition different from that of the plasma membrane, as well
as lower lateral membrane diffusion, higher ﬂip-ﬂop rate, and a
loss of phospholipid asymmetry (Laulagnier et al., 2004, 2005).
These traits are thought to contribute to higher stability of the
exosomes at neutral pH, extending their lifetime in the extra-
cellular environment, and permitting fusion with other cellular
membranes.
There is an intimate relationship between the mast cell endoso-
mal and secretory pathways, and mast cell granules are classiﬁed as
modiﬁed lysosomes (i.e.,“secretory lysosomes; Blott and Grifﬁths,
2002). Raposo et al. (1997) described three types of endoso-
mal/lysosomal compartments in BMMCs: type I compartments
which colocalize with mannose-6-phosphate receptors, lamp-1,
and lamp 2, type II which colocalize with serotonin and have an
electron dense core, and an electron dense type III compartment.
Both type I and type II are MVBs that contain exosomes. The
exosomes within the different compartments possess distinct pro-
tein proﬁles (Skokos et al., 2003; Figures 3A,B from the Wilson
lab). The differences between exosome populations within mast
cells could be indicative of an ability of mast cells to modulate the
immune response differentially based on activation state. Con-
sistent with this hypothesis, although all mast cell lines (MC/9,
P815, RBL-2H3, and HMC-1) and BMMCs pretreated with IL-4
can secrete exosomes constitutively (Skokos et al., 2001a,b), secre-
tion of exosomes speciﬁcally from the secretory MVBs/lysosomes
(those that colocalize with serotonin) requires mast cell activation
through FcεRI crosslinking or treatment with a Ca2+ ionophore
(Raposo et al., 1997; Vincent-Schneider et al., 2001).
A wide variety of cells secrete exosomes (Denzer et al., 2000),
and the presence of exosomes in many biological ﬂuids, includ-
ing breast milk (Admyre et al., 2007), urine (Pisitkun et al., 2004),
saliva (Palanisamy et al., 2010), plasma (Caby et al., 2005), and
bronchoalveolar lavage ﬂuid (Dawicki et al., 2010), strongly sug-
gests a physiological role in modulation of immune responses.
Although there are proteins that are typical to exosomes (e.g.,
tetraspanins, cytoskeletal proteins, and chaperones), the actual
content varies depending on the cellular source. Thus, it is rea-
sonable to expect that exosomes derived from different cells will
lead to very speciﬁc effects on other target cells and tissues. Mast
cell exosomes have been reported to contain anywhere from 200 to
400 different proteins, and althoughmany of these proteins are not
identiﬁed, known constituents include TNFα, prothrombin and
Plasminogen Activator Inhibitor Type I (Al-Nedawi et al., 2005).
Considerable attention has been paid to the functional roles
for MHCII on mast cell exosomes (Raposo et al., 1997; Vincent-
Schneider et al., 2001). Raposo et al. (1997) characterized the
accumulation of MHCII molecules in the prelysosomal/lysosomal
compartments of BMMCs, where exosomes are located. MHCII
molecules were found almost exclusively on exosome membranes,
with only a small percentage of labeling occurring on the plasma
membrane or the limitingmembrane of theMVB. BMMCs, aswell
as RBL-2H3 cells transfected to express MHCII, show slow matu-
ration of MHCII such that persistent association of the invariant
chain can obscure peptide loading (Raposo et al., 1997; Vincent-
Schneider et al., 2001). Skokos et al. (2003) suggested that even
if MHCII-peptide presentation is low, antigen can be bound in a
complex with chaperones such as hsc70 for loading onto MHCII
complexes found within target cells. Other studies have focused on
the relative stimulatory capacity of mast cell exosomes, suggesting
that there are clear differences between the responses of T and B
cells based on the excitatory state of the mast cell during exosome
release (Skokos et al., 2001a,b; de Vries et al., 2011).
We have addressed these questions using the RBL-2H3 cell line
as a model system and conﬁrmed that mast cells release exosomes
through both basal (constitutive) secretion and regulated exocy-
tosis (Figure 3, from Wilson Lab). Vesicles released by these two
secretory pathways have distinct protein proﬁles (Figure 3A). As
shown in Figure 3B (top), vesicles recovered from the supernatant
of resting, cultured RBL cells are remarkably uniform, composed
mostly of 100 nm exosomes with a dense core. In contrast, these
distinctive vesicles (arrows in Figure 3B, bottom) represent only a
subpopulation of the material released by activated cells. Insight
into these distinct processes is provided by examination of the
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FIGURE 3 | RBL-2H3 exosomes. (A) Ponceau stain of protein proﬁles
from exosomes released from MVBs constitutively (Const.) as compared
to exosomes released from secretory lysosomes (RE) run on SDS-PAGE.
(B)TEM of exosomes after secretion from cells that originated in MVBs
(top left panel) or secretory lysosomes (bottom left panel, arrows; scale
bars=0.1μm) and (C) exosomes still present in cells within MVBs (upper
right panel) or secretory lysosomes (lower right panel, SL). Scale
bars=0.5μm. (D) Blots demonstrating that exosomes contain intact
FcεRI. Immunoprecipitation of lysates with an α-FcεRI α antibody followed
by blotting for β and γ demonstrate the subunits exist in a complexed
state. (E) Exosomes with intact, IgE-bound receptors bind antigen and
mediate reuptake of exosome-antigen complexes in coated pits.
Representative TEM images of RBL-2H3 cells primed with α-DNP IgE and
stimulated with DNP–BSA-colloidal gold showing that gold-conjugated
ligands target both the plasma membrane and exosome-associated FcεRI.
The presence of multiple exosomes within coated pits (denoted with
arrows labeled CP) shows reabsorption of exosomes with crosslinked
receptor. Scale bars=0.1μm.
MVB of intact cells after ﬁxation and preparation of ultra-thin
sections for transmission electron microscopy (Figure 3C). In the
top image of Figure 3C, lines point to two vesicles that are tightly
packed with exosomes, suggesting these are the sources of consti-
tutively secreted exosomes. In the lower image,“SL”marks a typical
secretory lysosome that contains many convoluted vesicular struc-
tures as well as a number of exosomes. It is this compartment that
fuses with the plasma membrane in response to antigen or calcium
ionophore stimulation.
We further made the novel discovery that exosomes from both
types of preparations contain intact FcεRI, as demonstrated by
immunoprecipitation of the FcεRIα subunit and detection of both
FcεRI β and γ subunits by immunoblotting (Figure 3D). Impor-
tantly, electron microscopy experiments reveal that the exosomes
are oriented “right-side out,” exposing FcεRI–IgE complexes and
mediating their reuptake when crosslinked by polyvalent antigen
(Figure 3E). For the mast cell, this represents a potential ampli-
ﬁcation mechanism where antigen is recycled back for continued
crosslinking. In the context of exosome uptake by dendritic cells, B
cells and other antigen presenting cells, we suggest that the deliv-
ery of mast cell-derived exosomes loaded with a cargo of IgE and
antigen may promote robust presentation of allergenic peptides to
T cells.
Finally, a novel role for mast cell exosomes may be the delivery
of luminal contents to cells that engulf the vesicle. For exam-
ple, mast cell exosomes can incorporate functional mRNA and
microRNA into their lumens, which has been termed “exosomal
shuttle RNA”or esRNA (Lotvall andValadi, 2007; Eldh et al., 2010).
This unique packaging mechanism can potentially initiate protein
translation in the target cell using mRNA originally synthesized
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FIGURE 4 | Summary of types of mast cell intercellular communication occurring through formation of synapses or direct contacts versus through
soluble factors or mast cell exosomes.
in the mast cells. It has been proposed that mast cells utilize this
mechanism to broadcast local environmental signals to periph-
eral locations. Additionally, the packaging and transfer of esRNA
between mast cells has been suggested as a mechanism for protec-
tion from harmful environmental effects such as oxidation or UV
damage (Eldh et al., 2010).
CONCLUSION
The role for mast cells in modiﬁcation of immune responses is
extending beyond the scope of allergy alone. With capacity to
secrete a variety of soluble mediators, form synapses, and deliver
exosomes throughout the body, mast cells have several functional
roles in immune modulation (Figure 4). Although this review
focuses on the mechanism of mast cell modulation of the immune
system, mast cells also serve as the target cells for modulation
by other immune cells through soluble mediators, direct contact,
or membrane vesicles/exosomes (Bhattacharyya et al., 1998;
Sheﬂer et al., 2010). Further elucidation of mast cell functions in
the context of the tissue microenvironment will surely demon-
strate the importance of this cell population as an emerging
frontier in immunology.
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